2019 annual financial data
Denali Therapeutics 2019 Operating margin
Denali Therapeutics 2019 operating margin with verified reported values.
Direct answer
Operating margin was -799.1%.
Operating income was -213,184,000 USD and net income was -197,614,000 USD.
Operating cash flow was -151,576,000 USD.
Get free Denali Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 26,678,000 USD
- Operating income
- -213,184,000 USD
- Net income
- -197,614,000 USD
- Operating cash flow
- -151,576,000 USD